CD137 (4-1 BB Receptor)
| Aliases: | 4-1BB, CD137, CDw137, ILA |
|---|---|
| Other: | tumor necrosis factor receptor superfamily member 9|4-1BB ligand receptor|CD137 antigen|T cell antigen ILA|T-cell antigen 4-1BB homolog|homolog of mouse 4-1BB|induced by lymphocyte activation (ILA)|interleukin-activated receptor, homolog of mouse Ly63|receptor protein 4-1BB |
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced... see more
APC-Vio770
| Common Laser: | 628-640 |
|---|---|
| Common Filter: | 780/60 |
| Excitation Peak: | 652 |
| Emission Peak: | 775 |
APC-Vio®770 from Miltenyi is a tandem fluorophore with APC as the donor and has an excitation peak at 652 nm and an emission peak at 775 nm, and is spectrally similar to APC-Cy® 7 (GE Healthcare) APC-H7 (BD Biosciences), APC-eFluor™ 780 (ThermoFisher Scientific), APC-Vio®770 (Miltenyi Biotec), and APC-Fire™ 750 (BioLegend). The Vio® dye family are products of Miltenyi Biotec, with many antibod... see more
Popular CD137 (4-1 BB Receptor) APC-Vio770 Antibodies
| Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
|---|---|---|---|---|---|---|
|
Miltenyi Biotec 130-130-057 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD137 (4-1 BB Receptor) Human |
Human IgG1 REA765 |
100 tests in 200 µL $400 |
Details | |
|
Miltenyi Biotec 130-130-122 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD137 (4-1 BB Receptor) Human |
Human IgG1 REA765 |
30 tests in 60 µL $170 |
Details | |
|
Miltenyi Biotec 130-115-569 |
FC | CD137 (4-1 BB Receptor) Mouse |
Human IgG1 REA936 |
30 µg in 200 µL $165 |
Details | |
| Browse CD137 (4-1 BB Receptor) / APC-Vio770 antibodies. | ||||||


